PTX3 and neoplasm: In addition, as a consequence of PTX3 upregulation, in vivo grafting in immune-deficient mice resulted in reduced tumor burden/growth capacity of 5637-hPTX3 cells in comparison with 5637-Mock and wild-type cells (Figure 3G).